SCHEMBL3981483

SCHEMBL3981483

Fc1cccc(CN(CCN2CCOCC2)Cc2nccn2Cc2cc(Cl)cc(Cl)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CCNT1 O60563 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90B1 P14625 1/20 0.38
▸ PIK3CD O00329 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ CDK9 P50750 1/20 0.36
▸ STAT6 P42226 1/20 0.36
▸ SIGMAR1 Q99720 2/20 0.35
▸ FNTA P49354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3982292 0.89 CCNT1 (0.39) ALDH1A1CCNT1MEN1KMT2AHSD17B10
SCHEMBL3979505 0.85 HSP90AA1 (0.42) ALDH1A1TSHRMEN1KMT2AHSD17B10
SCHEMBL13720182 0.83 HSP90AA1 (0.42) ALDH1A1THRBPOLBMEN1KMT2A
SCHEMBL3978850 0.82 HSP90AA1 (0.43) ALDH1A1THRBPOLBMEN1KMT2A
SCHEMBL3980419 0.82 OPRD1 (0.43) MAPK1POLBCCNT1HSP90AA1HSP90B1
SCHEMBL3980102 0.80 HSP90AA1 (0.47) LMNAHSP90AA1HSP90B1
SCHEMBL3984837 0.79 HSP90AA1 (0.45) ALDH1A1THRBPOLBHSP90AA1HSP90B1
SCHEMBL3983750 0.78 HSP90AA1 (0.43) ALDH1A1THRBPOLBTSHRMEN1
SCHEMBL3979518 0.77 HSP90AA1 (0.39) ALDH1A1THRBPOLBMEN1KMT2A
SCHEMBL3983787 0.77 HSP90AA1 (0.47) ALDH1A1LMNAHSP90AA1HSP90B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572921-B2 Substituted benzylimidazoles useful for the treatment of inflammatory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-08-11 — — US claimed
US-20060252811-A1 SUBSTITUTED BENZYLIMIDAZOLES USEFUL FOR THE TREATMENT OF INFLAMMATORY DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-11-09 — — US claimed
US-7572921-B2 Substituted benzylimidazoles useful for the treatment of inflammatory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-08-11 — — US disclosed
US-7572921-B2 Substituted benzylimidazoles useful for the treatment of inflammatory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252811-A1 SUBSTITUTED BENZYLIMIDAZOLES USEFUL FOR THE TREATMENT OF INFLAMMATORY DISEASES IL4I1, NFKBIA, BRD4 ALDH1A1 421/4885LMNA 3170/4885GAA 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback